Physician profile
Austin Hill
NPI 1225233489
$10,068.97
in general payments reported to CMS, 2019-2025
20 companies · $2,651 in 2025
The $2,651 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.91 · 2020: $36.27 · 2021: $173 · 2022: $490 · 2023: $467 · 2024: $6,156 · 2025: $2,651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,100 · Food and Beverage: $2,562 · Travel and Lodging: $1,588 · Education: $24.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,100.00 |
| Food and Beverage | $2,562.38 |
| Travel and Lodging | $1,588.25 |
| Education | $24.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $5,526.49 | 2024 | Prevena Restor Arthroform, Prevena Restor Axioform, Prevena |
| Smith+Nephew, INC. | $2,412.57 | 2022-2025 | Evos, Trigen Intertan, Maverick |
| Stryker Corporation | $560.70 | 2019-2025 | Variax, Hoffmann, Triathlon |
| Depuy Synthes Sales INC. | $282.56 | 2019-2024 | Va-Lcp, Na |
| Osteocentric Technologies, INC. | $187.53 | 2022-2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Illuminoss Medical, INC. | $145.75 | 2022-2025 | Photodynamic Bone Stabilization Procedure Pack |
| Femselect INC. | $135.00 | 2023 | Enplace |
| Arthrex, INC. | $131.25 | 2024 | |
| Janssen Biotech, INC. | $129.01 | 2020-2022 | |
| Biocomposites INC | $127.95 | 2024 | |
| Core Surgical Group | $122.91 | 2024-2025 | |
| Sanara Medtech INC. | $108.82 | 2025 | Celleraterx |
| Medacta USA, INC. | $100.24 | 2023 | Gmk Sphere |
| Pfizer INC. | $24.89 | 2025 | |
| Abbott Laboratories | $22.32 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossur Americas, INC. | $14.40 | 2025 | |
| Si-Bone, INC. | $13.65 | 2025 | |
| Novo Nordisk INC | $11.58 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $11.35 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$275,500.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.